Cited by 38Dermatology and Skin DiseasesFood Allergy and Anaphylaxis ResearchContact Dermatitis and Allergies

The skin microbiome in pediatric atopic dermatitis and food allergy

Open access
Tham, Elizabeth Huiwen, Chia, Minghao, Riggioni, Carmen, Nagarajan, Niranjan, Common, John E. A., Kong, Heidi H.·2024·Allergy

Published version of a preprint

Abstract

The skin microbiome is an extensive community of bacteria, fungi, mites, viruses and archaea colonizing the skin. Fluctuations in the composition of the skin microbiome have been observed in atopic dermatitis (AD) and food allergy (FA), particularly in early life, established disease, and associated with therapeutics. However, AD is a multifactorial disease characterized by skin barrier aberrations modulated by genetics, immunology, and environmental influences, thus the skin microbiome is not the sole feature of this disease. Future research should focus on mechanistic understanding of how early‐life skin microbial shifts may influence AD and FA onset, to guide potential early intervention strategies or as microbial biomarkers to identify high‐risk infants who may benefit from possible microbiome‐based biotherapeutic strategies. Harnessing skin microbes as AD biotherapeutics is an emerging field, but more work is needed to investigate whether this approach can lead to sustained clinical responses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/all.16044

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a murine model, skin colonized by S. aureus leads to activation of dermal antigen-presenting cells after exposure of inflamed skin to exogenous food allergens, expansion of germinal center IgE+ B cells, generation of IgE specific to food allergens, and inflammatory cytokines.

    “In a murine model, skin colonized by S. aureus leads to the activation of dermal antigen-presenting cells after exposure of inflamed skin to exogenous food allergens, expansion of germinal center IgE + B cells, and generation of IgE specific to food allergens, in addition to inflammatory cytokines (IL-4, IL-5, thymic stromal lymphopoietin (TSLP) and IL-33).”

    From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [12]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Epicutaneous exposure combined with staphylococcal enterotoxin B increased allergenic responses to eggs and peanuts.

    “it was demonstrated that epicutaneous exposure combined with staphylococcal enterotoxin B increased allergenic responses to eggs and peanuts.”

    From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [12]

    The review reports that combined epicutaneous exposure to staphylococcal enterotoxin B and ovalbumin increased ovalbumin-specific antibodies in a murine model. It also reports increased peanut-specific Th2 responses in mice exposed to the toxin and peanut extract. The claim omits that these were mouse experiments and describes the ovalbumin result more broadly as a response to eggs. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Cutaneous microbial dysbiosis contributes to barrier dysfunction, modulating allergic sensitization.

    “Thus, cutaneous microbial dysbiosis also contributes to barrier dysfunction, modulating allergic sensitization.”

    From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [12]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 87

  1. Bylund S, Kobyletzki LB, Svalstedt M, et al. Prevalence and inci- dence of atopic dermatitis: a systematic review. Acta Derm Venereol. 2020;100:adv00160. doi:10.2340/00015555-3510 · DOI
  2. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396:345-360. doi:10.1016/s0140-6736(20)31286-1 · DOI
  3. Zheng TYJ, Hee OM, Zhu Z. The atopic march: progression from atopic dermatits to allergic rhinitis and asthma. Allergy Asthma Immunol Res. 2011;3:67-73.
  4. Lack G, Fox D, Northstone K, et al. Factors associated with the development of peanut allergy in childhood. N Engl J Med. 2003;348:977-985. doi:10.1056/NEJMoa013536 · DOI
  5. Gallo RL. Human skin is the largest epithelial surface for interac- tion with microbes. J Invest Dermatol. 2017;137(6):1213-1214. doi:10.1016/j.jid.2016.11.045 · DOI
  6. Chen YE, Fischbach MA, Belkaid Y. Skin microbiota-host interac- tions. Nature. 2018;553:427-436. doi:10.1038/nature25177 · DOI
  7. Naik S, Bouladoux N, Wilhelm C, et al. Compartmentalized control of skin immunity by resident commensals. Science. 2012;337:1115- 1119. doi:10.1126/science.1225152 · DOI · Paper page
  8. Severn MM, Williams MR, Shahbandi A, et al. The ubiquitous human skin commensal Staphylococcus hominis protects against opportunistic pathogens. MBio. 2022;13:e0093022. doi:10.1128/ mbio.00930-22 · DOI
  9. Kobayashi T, Glatz M, Horiuchi K, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 2015;42:756-766. doi:10.1016/j.immuni.2015.03.014 · DOI
  10. Chng KR, Tay AS, Li C, et al. Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare. Nat Microbiol. 2016;1:16106. doi:10.1038/nmicrobiol.2016.106 · DOI · Paper page
  11. Tay ASL, Li C, Nandi T, et al. Atopic dermatitis microbiomes stratify into ecologic dermotypes enabling microbial virulence and disease severity. J Allergy Clin Immunol. 2020;147:1329-1340. doi:10.1016/j. jaci.2020.09.031 · DOI
  12. Uberoi A, Bartow-McKenney C, Zheng Q, et al. Commensal micro- biota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor. Cell Host Microbe. 2021;29:1235- 1248.e1238. doi:10.1016/j.chom.2021.05.011 · DOI
  13. Yu J, Luo Y, Zhu Z, et al. A tryptophan metabolite of the skin mi- crobiota attenuates inflammation in patients with atopic dermati- tis through the aryl hydrocarbon receptor. J Allergy Clin Immunol. 2019;143:2108-2119.e2112. doi:10.1016/j.jaci.2018.11.036 · DOI
  14. Miajlovic H, Fallon PG, Irvine AD, et al. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol 2010; 126: 1184-1190.e1183. 20101030. DOI: 10.1016/j.jaci.2010.09.015 · DOI
  15. Totte JE, van der Feltz WT, Hennekam M, et al. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a sys- tematic review and meta-analysis. Br J Dermatol. 2016;175:687- 695. doi:10.1111/bjd.14566 · DOI
  16. Cho SH, Strickland I, Boguniewicz M, et al. Fibronectin and fibrino- gen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol. 2001;108:269-274. doi:10.1067/ mai.2001.117455 · DOI
  17. Baurecht H, Rühlemann MC, Rodríguez E, et al. Epidermal lipid composition, barrier integrity, and eczematous inflammation are as- sociated with skin microbiome configuration. J Allergy Clin Immunol. 2018;141:1668-1676.e1616. doi:10.1016/j.jaci.2018.01.019 · DOI
  18. Byrd AL, Deming C, Cassidy SKB, et al. Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediat- ric atopic dermatitis. Sci Transl Med. 2017;9:9. doi:10.1126/sci- translmed.aal4651 · DOI
  19. Oh J, Freeman AF, Park M, et al. The altered landscape of the human skin microbiome in patients with primary immunodeficien- cies. Genome Res. 2013;23:2103-2114. doi:10.1101/gr.159467.113 · DOI
  20. Tham KC, Lefferdink R, Duan K, et al. Distinct skin microbiome community structures in congenital ichthyosis. Br J Dermatol. 2022;187:557-570. doi:10.1111/bjd.21687 · DOI
  21. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974;90:525-530. doi:10.1111/j.1365-2133.1974.tb06447.x · DOI
  22. Cheung GYC, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12:547-569. doi:10.1080/21 505594.2021.1878688 · DOI
  23. Deng L, Costa F, Blake KJ, et al. S. aureus drives itch and scratch- induced skin damage through a V8 protease-PAR1 axis. Cell. 2023;186:5375-5393.e5325. doi:10.1016/j.cell.2023.10.019 · DOI
  24. Key FM, Khadka VD, Romo-González C, et al. On-person adaptive evolution of Staphylococcus aureus during treatment for atopic der- matitis. Cell Host Microbe. 2023;31:593-603.e597. doi:10.1016/j. chom.2023.03.009 · DOI
  25. Saheb Kashaf S, Harkins CP, Deming C, et al. Staphylococcal diver- sity in atopic dermatitis from an individual to a global scale. Cell Host Microbe. 2023;31:578-592.e576. doi:10.1016/j.chom.2023.03.010 · DOI
  26. Wollenberg A, Zoch C, Wetzel S, et al. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J Am Acad Dermatol. 2003;49:198-205. doi:10.1067/ s0190-9622(03)00896-x · DOI
  27. Beck LA, Boguniewicz M, Hata T, et al. Phenotype of atopic der- matitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol. 2009;124:260-269. doi:10.1016/j.jaci.2009.05.020 · DOI
  28. Schlievert PM, Roller RJ, Kilgore SH, et al. Staphylococcal TSST-1 association with eczema Herpeticum in humans. mSphere. 2021;6:e0060821. doi:10.1128/mSphere.00608-21 · DOI
  29. Bin L, Kim BE, Brauweiler A, et al. Staphylococcus aureus α-toxin modulates skin host response to viral infection. J Allergy Clin Immunol. 2012;130:683-691.e682. doi:10.1016/j. jaci.2012.06.019 · DOI
  30. Tao R, Li R, Wang R. Dysbiosis of skin mycobiome in atopic derma- titis. Mycoses. 2022;65:285-293. doi:10.1111/myc.13402 · DOI
  31. Li H, Goh BN, Teh WK, et al. Skin commensal Malassezia globosa secreted protease attenuates Staphylococcus aureus biofilm for- mation. J Invest Dermatol. 2018;138:1137-1145. doi:10.1016/j. jid.2017.11.034 · DOI
  32. Edslev SM, Andersen PS, Agner T, et al. Identification of cuta- neous fungi and mites in adult atopic dermatitis: analysis by tar- geted 18S rRNA amplicon sequencing. BMC Microbiol. 2021;21:72. doi:10.1186/s12866-021-02139-9 · DOI
  33. Savinko T, Matikainen S, Saarialho-Kere U, et al. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by trigger- ing factors. J Invest Dermatol. 2012;132:1392-1400. doi:10.1038/ jid.2011.446 · DOI
  34. Scharschmidt TC, Vasquez KS, Truong HA, et al. A wave of reg- ulatory T cells into neonatal skin mediates tolerance to com- mensal microbes. Immunity. 2015;43:1011-1021. doi:10.1016/j. immuni.2015.10.016 · DOI · Paper page
  35. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010;107:11971-11975. doi:10.1073/pnas.1002601107 · DOI · Paper page
  36. Dominguez-Bello MG, De Jesus-Laboy KM, Shen N, et al. Partial restoration of the microbiota of cesarean-born infants via vagi- nal microbial transfer. Nat Med. 2016;22:250-253. doi:10.1038/ nm.4039 · DOI · Paper page
  37. Song SJ, Wang J, Martino C, et al. Naturalization of the microbi- ota developmental trajectory of cesarean-born neonates after vaginal seeding. Med. 2021;2:951-964.e955. doi:10.1016/j. medj.2021.05.003 · DOI
  38. Mueller NT, Differding MK, Sun H, et al. Maternal bacterial en- graftment in multiple body sites of cesarean section born neo- nates after vaginal seeding-a randomized controlled trial. MBio. 2023;14:e0049123. doi:10.1128/mbio.00491-23 · DOI
  39. Xiong Z, Zhou L, Chen Y, et al. Prevalence of eczema between cesarean-born and vaginal-born infants within 1 year of age: a systematic review and meta-analysis. Eur J Pediatr. 2022;181:2237- 2247. doi:10.1007/s00431-022-04436-5 · DOI
  40. Kennedy EA, Connolly J, Hourihane JOB, et al. Skin microbiome be- fore development of atopic dermatitis: early colonization with com- mensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year. J Allergy Clin Immunol. 2017;139:166- 172. doi:10.1016/J.JACI.2016.07.029 · DOI
  41. Meylan P, Lang C, Mermoud S, et al. Skin colonization by Staphylococcus aureus precedes the clinical diagnosis of atopic dermatitis in infancy. J Invest Dermatol. 2017;137:2497-2504. doi:10.1016/j.jid.2017.07.834 · DOI
  42. Nakamura Y, Takahashi H, Takaya A, et al. Staphylococcus Agr vir- ulence is critical for epidermal colonization and associates with atopic dermatitis development. Sci Transl Med. 2020;12:eaay4068. doi:10.1126/scitranslmed.aay4068 · DOI
  43. Levin ME, Botha M, Basera W, et al. Environmental factors associ- ated with allergy in urban and rural children from the south African food allergy (SAFFA) cohort. J Allergy Clin Immunol. 2020;145:415- 426. doi:10.1016/j.jaci.2019.07.048 · DOI
  44. Steiman CA, Evans MD, Lee KE, et al. Patterns of farm exposure are associated with reduced incidence of atopic dermatitis in early life. J Allergy Clin Immunol. 2020;146:1379-1386.e1376. doi:10.1016/j. jaci.2020.06.025 · DOI
  45. Brauer M, Hoek G, Smit HA, et al. Air pollution and development of asthma, allergy and infections in a birth cohort. Eur Respir J. 2007;29:879-888. doi:10.1183/09031936.00083406 · DOI
  46. Saulyte J, Regueira C, Montes-Martínez A, et al. Active or passive exposure to tobacco smoking and allergic rhinitis, allergic dermati- tis, and food allergy in adults and children: a systematic review and meta-analysis. PLoS Med. 2014;11:e1001611. doi:10.1371/journal. pmed.1001611 · DOI · Paper page
  47. Alkotob SS, Cannedy C, Harter K, et al. Advances and novel devel- opments in environmental influences on the development of atopic diseases. Allergy. 2020;75:3077-3086. doi:10.1111/all.14624 · DOI
  48. Xian M, Wawrzyniak P, Rückert B, et al. Anionic surfactants and commercial detergents decrease tight junction barrier integrity in human keratinocytes. J Allergy Clin Immunol. 2016;138:890-893. e899. doi:10.1016/j.jaci.2016.07.003 · DOI
  49. Oh J, Conlan S, Polley EC, Segre JA, Kong HH. Shifts in human skin and nares microbiota of healthy children and adults. Genome Med. 2012;4(10):77. doi:10.1186/gm378 · DOI
  50. Park J, Schwardt NH, Jo JH, et al. Shifts in the skin bacterial and fungal communities of healthy children transitioning through puberty. J Invest Dermatol. 2022;142(1):212-219. doi:10.1016/j. jid.2021.04.034 · DOI
  51. Wan M, Yang X. Maternal exposure to antibiotics and risk of atopic dermatitis in childhood: a systematic review and meta-analysis. Front Pediatr. 2023;11:1142069. doi:10.3389/fped.2023.1142069 · DOI
  52. Ahmadizar F, Vijverberg SJH, Arets HGM, et al. Early-life antibi- otic exposure increases the risk of developing allergic symptoms later in life: a meta-analysis. Allergy. 2018;73:971-986. doi:10.1111/ all.13332 · DOI
  53. Jo JH, Harkins CP, Schwardt NH, et al. Alterations of human skin microbiome and expansion of antimicrobial resistance after sys- temic antibiotics. Sci Transl Med. 2021;13:eabd8077. doi:10.1126/ scitranslmed.abd8077 · DOI
  54. Grech A, Collins CE, Holmes A, et al. Maternal exposures and the infant gut microbiome: a systematic review with meta- analysis. Gut Microbes. 2021;13:1-30. doi:10.1080/19490976.2 021.1897210 · DOI
  55. Chiesa Fuxench Z, Mitra N, Del Pozo D, et al. In utero or early in life exposure to antibiotics and the risk of childhood atopic derma- titis, a population-based cohort study. Br J Dermatol. 2023;ljad428. doi:10.1093/bjd/ljad428. Online ahead of print. · DOI
  56. Mubanga M, Lundholm C, D'Onofrio BM, et al. Association of early life exposure to antibiotics with risk of atopic dermati- tis in Sweden. JAMA Netw Open. 2021;4:e215245. doi:10.1001/ jamanetworkopen.2021.5245 · DOI
  57. Chiu LS, Ho MS, Hsu LY, et al. Prevalence and molecular characteris- tics of Staphylococcus aureus isolates colonizing patients with atopic dermatitis and their close contacts in Singapore. Br J Dermatol. 2009;160:965-971. doi:10.1111/j.1365-2133.2009.09038.x · DOI
  58. Chia M, Naim ANM, Tay ASL, et al. Shared signatures and diver- gence in skin microbiomes of children with atopic dermatitis and their caregivers. J Allergy Clin Immunol. 2022;150:894-908. doi:10.1016/j.jaci.2022.01.031 · DOI
  59. Hogan PG, Parrish KL, Mork RL, et al. HOME2 study: house- hold versus personalized decolonization in households of chil- dren with methicillin-resistant Staphylococcus aureus skin and soft tissue infection-a randomized clinical trial. Clin Infect Dis. 2021;73:e4568-e4577. doi:10.1093/CID/CIAA752 · DOI
  60. Gonzalez ME, Schaffer JV, Orlow SJ, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol. 2016;75:481- 493.e488. doi:10.1016/j.jaad.2016.04.066 · DOI
  61. Khadka VD, Key FM, Romo-González C, et al. The skin microbiome of patients with atopic dermatitis normalizes gradually during treat- ment. Front Cell Infect Microbiol. 2021;11:720674. doi:10.3389/ fcimb.2021.720674 · DOI
  62. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest. 1994;94:870-876. doi:10.1172/JCI117408 · DOI
  63. Neis MM, Peters B, Dreuw A, et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact der- matitis. J Allergy Clin Immunol. 2006;118:930-937. doi:10.1016/j. jaci.2006.07.015 · DOI
  64. Drucker AM, Ellis AG, Bohdanowicz M, et al. Systemic immunomod- ulatory treatments for patients with atopic dermatitis: a systematic review and network meta-analysis. JAMA Dermatol. 2020;156:659- 667. doi:10.1001/JAMADERMATOL.2020.0796 · DOI
  65. Press Release. FDA approves Dupixent® (dupilumab) as first bio- logic medicine for children aged 6 months to 5 years with moderate- to-severe atopic dermatitis -Sanofi.
  66. Callewaert C, Nakatsuji T, Knight R, et al. IL-4Rα blockade by Dupilumab decreases Staphylococcus aureus colonization and in- creases microbial diversity in atopic dermatitis. J Invest Dermatol. 2020;140:191-202.e197. doi:10.1016/J.JID.2019.05.024 · DOI
  67. Simpson EL, Schlievert PM, Yoshida T, et al. Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dup- ilumab treatment. J Allergy Clin Immunol. 2023;152:1179-1195. doi:10.1016/j.jaci.2023.05.026 · DOI
  68. Beck LA, Bieber T, Weidinger S, et al. Tralokinumab treatment improves the skin microbiota by increasing the microbial diver- sity in adults with moderate-to-severe atopic dermatitis: analy- sis of microbial diversity in ECZTRA 1, a randomized controlled trial. J Am Acad Dermatol. 2022;88:816-823. doi:10.1016/j. jaad.2022.11.047 · DOI · Paper page
  69. Hussain M, Borcard L, Walsh KP, et al. Basophil-derived IL-4 pro- motes epicutaneous antigen sensitization concomitant with the development of food allergy. J Allergy Clin Immunol. 2018;141:223- 234.e225. doi:10.1016/j.jaci.2017.02.035 · DOI
  70. Galand C, Leyva-Castillo JM, Yoon J, et al. IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells. J Allergy Clin Immunol. 2016;138:1356-1366. doi:10.1016/j. jaci.2016.03.056 · DOI
  71. Savinko T, Lauerma A, Lehtimäki S, et al. Topical superan- tigen exposure induces epidermal accumulation of CD8+ T cells, a mixed Th1/Th2-type dermatitis and vigorous pro- duction of IgE antibodies in the murine model of atopic dermatitis. J Immunol. 2005;175:8320-8326. doi:10.4049/ jimmunol.175.12.8320 · DOI
  72. Forbes-Blom E, Camberis M, Prout M, et al. Staphylococcal- derived superantigen enhances peanut induced Th2 responses in the skin. Clin Exp Allergy. 2012;42:305-314. doi:10.1111/j.1365-2222.2011.03861.x · DOI
  73. Jones AL, Curran-Everett D, Leung DYM. Food allergy is associ- ated with Staphylococcus aureus colonization in children with atopic dermatitis. J Allergy Clin Immunol. 2016;137:1247-1248.e1243. doi:10.1016/j.jaci.2016.01.010 · DOI
  74. Tsilochristou O, du Toit G, Sayre PH, et al. Association of Staphylococcus aureus colonization with food allergy occurs inde- pendently of eczema severity. J Allergy Clin Immunol. 2019;144:494- 503. doi:10.1016/j.jaci.2019.04.025 · DOI
  75. Kelleher MM, Cro S, Cornelius V, et al. Skin care interventions in infants for preventing eczema and food allergy. Cochrane Database Syst Rev. 2021;2:Cd013534. doi:10.1002/14651858.CD013534. pub2 · DOI
  76. Zhong Y, Samuel M, van Bever H, Tham EH. Reply to correspon- dence: emollients in infancy to prevent atopic dermatitis: a sys- tematic review and meta-analysis. Allergy. 2022;77:1934-1935. doi:10.1111/all.15309 · DOI
  77. Glatz M, Jo JH, Kennedy EA, et al. Emollient use alters skin bar- rier and microbes in infants at risk for developing atopic dermatitis. PLoS One. 2018;13:e0192443. doi:10.1371/journal.pone.0192443 · DOI
  78. Yamamoto-Hanada K, Kobayashi T, Mikami M, et al. Enhanced early skin treatment for atopic dermatitis in infants reduces food allergy. J Allergy Clin Immunol. 2023;152:126-135. doi:10.1016/j. jaci.2023.03.008 · DOI
  79. Yamamoto-Hanada K, Kobayashi T, Williams HC, et al. Early ag- gressive intervention for infantile atopic dermatitis to prevent development of food allergy: a multicenter, investigator-blinded, randomized, parallel group controlled trial (PACI study)-protocol for a randomized controlled trial. Clin Transl Allergy. 2018;8:47. doi:10.1186/s13601-018-0233-8 · DOI
  80. Paharik AE, Parlet CP, Chung N. Et al. coagulase-negative staphylococcal strain prevents Staphylococcus aureus col- onization and skin infection by blocking quorum sensing. Cell Host Microbe. 2017;22:746-756.e745. doi:10.1016/j. chom.2017.11.001 · DOI
  81. Zheng Y, Hunt RL, Villaruz AE, et al. Commensal Staphylococcus epidermidis contributes to skin barrier homeostasis by generating protective ceramides. Cell Host Microbe. 2022;30:301-313.e309. doi:10.1016/j.chom.2022.01.004 · DOI
  82. Cau L, Williams MR, Butcher AM, et al. Staphylococcus epidermidis protease EcpA can be a deleterious component of the skin microbi- ome in atopic dermatitis. J Allergy Clin Immunol. 2021;147:955-966. e916. doi:10.1016/j.jaci.2020.06.024 · DOI
  83. Shimamori Y, Pramono AK, Kitao T, et al. Isolation and charac- terization of a novel phage SaGU1 that infects Staphylococcus aureus clinical isolates from patients with atopic derma- titis. Curr Microbiol. 2021;78:1267-1276. doi:10.1007/ s00284-021-02395-y · DOI
  84. Gueniche A, Knaudt B, Schuck E. Et al. effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo- controlled clinical study. Br J Dermatol. 2008;159:1357-1363. doi:10.1111/j.1365-2133.2008.08836.x · DOI
  85. Nakatsuji T, Hata TR, Tong Y, et al. Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial. Nat Med. 2021;27:700- 709. doi:10.1038/s41591-021-01256-2 · DOI · Paper page
  86. Myles IA, Earland NJ, Anderson ED, et al. First-in-human top- ical microbiome transplantation with Roseomonas mucosa for atopic dermatitis. JCI Insight. 2018;3:e120608. doi:10.1172/jci. insight.120608 · DOI
  87. de Wit J, Totté JEE, van Mierlo MMF, et al. Endolysin treatment against Staphylococcus aureus in adults with atopic dermatitis: a randomized controlled trial. J Allergy Clin Immunol. 2019;144:860- 863. doi:10.1016/j.jaci.2019.05.020 · DOI

Cited by

Sorted by citations

Authors
Tham, E. H., Chia, M., Riggioni, C., Nagarajan, N., Common, J. E. A., & Kong, H. H.
Affiliations
  • National University of Singapore (SG)
  • Agency for Science, Technology and Research (SG)
  • National Institutes of Health (US)
Corresponding author
Tham, Elizabeth Huiwen
Venue
Allergy
Publisher
Wiley
Published
2024-02-03
Volume
79
Issue
6
Pages
1470-1484
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W4391514378
Cited by
38
References
8
Citations by year
2026: 14 · 2025: 15 · 2024: 9
FWCI
2.97
Type
journal article
Language
en
Open access
Locations
  • Allergy (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by-nc-nd)
Funders
  • Agency for Science, Technology and Research
  • National Institutes of Health
  • National Medical Research Council
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
  • Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
Keywords
skin microbiome, atopic dermatitis, food allergy, pediatric allergy, skin barrier dysfunction, microbial biomarkers, high-risk infants, early intervention
MeSH terms
Child, Dermatitis, Atopic, Food Hypersensitivity, Humans, Skin, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review